Science and Research

Heterogenous Disease Course and Long-Term Outcome of Children's Interstitial Lung Disease Related to Filamin A Gene Variants

Rationale: Variable disease course and outcomes have been reported in children's interstitial lung disease associated with FLNA (Filamin A gene) variants. Objectives: To further delineate long-term respiratory outcomes and identify potential contributing factors to severe disease course. Methods: We retrospectively collected longitudinal data from three centers on nine cases (one male) with FLNA variants and early respiratory disease onset (within the first 24 mo of life). Clinical, radiographic, and histopathologic data were analyzed, focusing on cardiorespiratory disease course. Results: All required early respiratory support (three invasive ventilation, three noninvasive ventilation, three supplemental oxygen), and all experienced frequent severe infective respiratory exacerbations. Three died in infancy from refractory respiratory failure and pulmonary hypertension (PH). The six surviving individuals were 3, 10, 11, 15, 18, and 33 years old at time of reporting. The extent of functional respiratory impairment decreased with age; at last follow-up, there were no individuals on home invasive ventilation, one on nocturnal noninvasive ventilation, four on oxygen, and one on no respiratory support. Spirometry consistently demonstrated moderate to severe obstructive defects (forced expiratory volume in 1 s/forced vital capacity [FVC] z-score, -3.76 to -1.77; percent predicted FVC, 31.5% to 92.1%). Seven required PH treatment in early childhood (7/9), and three of the survivors (3/6) still receive treatment. Radiologic and histopathologic findings were consistent among cases. Conclusions: Early mortality was common, but many survivors stabilized even after severe symptoms in infancy. All survivors had persistent obstructive defects on spirometry, and half have persistent or recurrent PH. These typical findings are suggestive of this rare diagnosis and should prompt consideration of genetic testing.

  • Carlens, J.
  • Johnson, K. T.
  • Bush, A.
  • Renz, D.
  • Hehr, U.
  • Laenger, F.
  • Hogg, C.
  • Wetzke, M.
  • Schwerk, N.
  • Rayment, J. H.

Keywords

  • Child
  • Child, Preschool
  • Humans
  • Male
  • Disease Progression
  • Filamins/genetics
  • Forced Expiratory Volume
  • *Lung
  • *Lung Diseases, Interstitial/genetics/therapy
  • Oxygen/therapeutic use
  • Retrospective Studies
  • Spirometry
  • Vital Capacity
  • Female
  • Filamin A
  • children’s interstitial lung disease
  • lung function testing
  • pulmonary hypertension
Publication details
DOI: 10.1513/AnnalsATS.202202-142OC
Journal: Ann Am Thorac Soc
Pages: 2021-2030 
Number: 12
Work Type: Original
Location: BREATH
Disease Area: DPLD
Partner / Member: MHH
Access-Number: 35767027

DZL Engagements

chevron-down